Curcumin and amla containing ointment for contact dermatitis : a randomised control trial of chemotherapy PICC patient
Not Applicable
- Conditions
- Health Condition 1: L231- Allergic contact dermatitis due toadhesivesHealth Condition 2: L235- Allergic contact dermatitis due toother chemical productsHealth Condition 3: L239- Allergic contact dermatitis, unspecified cause
- Registration Number
- CTRI/2023/06/053380
- Lead Sponsor
- Pharmanza Herbal Pvt Ltd,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age between 18-65 years of both the sex.
2. Patient with PICC line for chemotherapy having
3. Contact dermatitis of any grade 1- 4.
4. Patient willing to participate and give consent.
Exclusion Criteria
1. Patient with a known history of eczema and allergy.
2. Patient on antiallergic treatment/ taking medications.
3. The patients with known liver/Renal metastasis and impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method